Lopid 300 mg Capsules (Gemfibrozil)

If you are comparing lipid-lowering options, the detail that sets Lopid apart from most cholesterol medicines on the shelf is simple: it is a fibrate built around gemfibrozil, not a statin. That distinction changes which lipid patterns it is used for, how it is dosed, what it interacts with and who may be prescribed it. Understanding this before you order helps you decide whether the capsule matches the lipid problem being treated.

Lopid 300 mg Capsules: The Decision at a Glance

We list Lopid as 300 mg oral capsules, supplied in packs of 30, 60, 90, 120, 180, 270 or 360 capsules. There is one strength, one dosage form and no alternative release type in the current offer. The practical choice is therefore the pack quantity, based on the number of capsules prescribed and the planned review period, rather than a choice between different strengths.

Gemfibrozil is generally considered when triglycerides are an important part of the lipid problem. It is not interchangeable with a statin simply because both types of medicine can appear in a lipid-management plan. Your recent lipid results, cardiovascular risk, other medicines and ability to follow the twice-daily routine all affect whether Lopid is a suitable choice.

What Is Lopid and Where Does It Fit Among Cholesterol Treatments?

Lopid's active ingredient is gemfibrozil, a member of the fibrate class of lipid-regulating medicines (ATC code C10AB04). Fibrates are typically considered when triglycerides are markedly raised or for mixed dyslipidaemia that has not responded adequately to diet and other measures. This differs from the main role of statins, which usually focus on lowering LDL cholesterol and reducing cardiovascular risk.

Gemfibrozil can substantially reduce triglycerides and may raise HDL cholesterol modestly. Its effect on LDL is more variable: LDL may fall in some people, change little in others or occasionally rise when very high triglyceride levels fall. That is why the medicine should be matched to the complete lipid profile rather than selected from a total-cholesterol result alone.

Who May Consider Lopid Capsules?

Gemfibrozil is generally considered for adults whose blood tests show an appropriate lipid pattern, alongside a genuine effort at diet and lifestyle change rather than instead of it. Typical situations include:

• Severe hypertriglyceridaemia that has not settled sufficiently with dietary and lifestyle measures.
• Mixed dyslipidaemia in which raised triglycerides are a significant concern.
• A lipid pattern for which a prescriber has judged fibrate therapy to be a better fit than treatment focused mainly on LDL cholesterol.

Before treatment, clinicians may also consider secondary causes of raised triglycerides, including poorly controlled diabetes, excess alcohol intake, hypothyroidism and medicines that can alter lipid levels. Addressing those contributors remains important even when gemfibrozil is prescribed.

Safety and efficacy have not been established in children. Use during pregnancy or breastfeeding is generally not recommended: gemfibrozil is Australian Pregnancy Category B3, and it is not known whether it passes into human milk. Anyone who is pregnant, planning pregnancy or breastfeeding should discuss the treatment plan with a prescriber.

How Gemfibrozil Works and What That Means Day to Day

Gemfibrozil activates a nuclear receptor called PPAR-alpha. This increases pathways involved in clearing triglyceride-rich particles from the bloodstream and reduces the liver's production of VLDL, which carries much of the circulating triglyceride load. It can also produce a modest rise in HDL cholesterol.

The effect is gradual and cannot usually be felt. Taking a capsule does not provide an immediate symptom change, so blood tests rather than day-to-day sensations show whether treatment is working. Diet, physical activity, diabetes management and any other measures recommended by the treating clinician remain part of the plan.

Building a Routine: How to Take Lopid

The usual adult gemfibrozil dose is 1,200 mg daily, given as 600 mg twice a day approximately 30 minutes before the morning and evening meals. With the offered 300 mg capsules, a 600 mg dose corresponds to two capsules. Follow the exact regimen on your prescription or treatment instructions, as a clinician may adapt the plan to individual circumstances.

Consistency matters because lipid-lowering benefit develops with regular use rather than after a single dose. Practical routine points include:

• Take each prescribed dose at a similar time relative to the morning and evening meals.
• Swallow the capsules as directed and do not change the number taken without professional advice.
• If a dose is missed, take it when remembered unless it is nearly time for the next dose; do not take a double dose.
• Continue the recommended diet, exercise and other risk-reduction measures rather than treating Lopid as a replacement for them.
• Store the capsules at 20°C to 25°C, with brief excursions between 15°C and 30°C permitted. Keep the container tightly closed and away from moisture.

Package Sizes We Offer

We currently offer Lopid 300 mg capsules in packs of 30, 60, 90, 120, 180, 270 and 360 capsules. When comparing quantities, use the prescribed number of capsules per day and the intended supply period rather than assuming that one capsule equals one complete dose. At the usual adult regimen, for example, two 300 mg capsules are taken at each of two daily dosing times.

A smaller pack may be appropriate when treatment is being started or a lipid review is approaching. A larger pack may reduce how often an established supply needs to be reordered, provided the quantity is consistent with the treatment plan. It is also sensible to consider the expiry date, storage conditions and whether the prescriber expects the regimen to change after follow-up testing. Current pricing and stock for each quantity are shown in our product listing above, alongside payment options at checkout.

What Results Should You Expect and When?

Changes in triglycerides and other lipid measurements can begin during the first few weeks of regular gemfibrozil use. The timing of repeat blood tests varies according to the starting lipid levels, overall risk and treatment plan, so follow the schedule set by the treating clinician rather than relying on symptoms. Product information generally recommends reassessing the response and reconsidering therapy if an adequate lipid response has not been achieved after about three months.

Follow-up testing helps determine whether triglycerides have fallen enough, whether HDL or LDL has changed and whether the medicine should be continued. The benefit depends on ongoing adherence. If treatment is stopped, its lipid-lowering effect is not expected to persist indefinitely.

What Safety Checks Should You Complete Before Starting Lopid?

Before starting gemfibrozil, review personal health conditions, pregnancy or breastfeeding status and all current medicines with a pharmacist or prescriber. Fibrates carry class-specific risks that can be overlooked when attention is focused only on the lipid numbers.

Gemfibrozil is contraindicated in people with hypersensitivity to gemfibrozil or an ingredient, severe liver or kidney dysfunction and pre-existing gallbladder disease. A history of gallstones, unexplained liver-test abnormalities or previous muscle problems with lipid medicines should be discussed before use.

Commonly reported adverse effects are mainly gastrointestinal and can include indigestion, abdominal discomfort, diarrhoea, nausea or vomiting. Headache, dizziness, tiredness, rash and blurred vision may also occur. Dizziness or visual disturbance can affect driving or machinery use, so it is sensible to learn how the medicine affects you before relying on either.

Muscle pain, tenderness, cramps or unexplained weakness should be reported promptly, particularly if accompanied by fever, marked tiredness or dark urine. These can indicate myopathy and, rarely, rhabdomyolysis. Urgent assessment is also appropriate for a severe allergic reaction, yellowing of the skin or eyes, persistent upper abdominal pain or other symptoms that could suggest liver or gallbladder trouble.

Monitoring commonly includes a lipid profile and periodic liver-function assessment. Kidney function, blood glucose, clotting tests or blood-cell counts may also be checked when medical history or interacting medicines make them relevant. Monitoring should be arranged by the treating health professional and should not be replaced by how well you feel.

Interactions and Practical Precautions

Gemfibrozil has several clinically important interactions. Some require additional monitoring, while others are contraindications:

• Repaglinide is contraindicated with gemfibrozil because the combination can cause severe and prolonged hypoglycaemia.
• Simvastatin is contraindicated with gemfibrozil because of the increased risk of myopathy and rhabdomyolysis. Other statins can also increase muscle toxicity and should be combined with gemfibrozil only when a prescriber has assessed the risks, selected an appropriate regimen and arranged monitoring.
• Warfarin and other anticoagulants can have their effects increased, so the dose and clotting-test schedule may need adjustment.
• Other glucose-lowering medicines may have an enhanced effect. People with diabetes may need closer blood-glucose monitoring or changes to treatment.
• Other medicines associated with muscle toxicity can add to the risk of muscle injury and should be reviewed before treatment begins.

Gemfibrozil affects several drug-metabolising and transport pathways, so this list is not exhaustive. Share a complete list of prescription medicines, non-prescription products and supplements with a pharmacist or prescriber before starting Lopid and whenever another medicine is added.

Lopid, Fenofibrate, Rosuvastatin and Atorvastatin: How Do They Compare?

Gemfibrozil is one of several lipid-regulating options. Fenofibrate belongs to the same fibrate class and can be considered for a similar triglyceride-focused problem, while rosuvastatin and atorvastatin are statins used primarily for LDL reduction and cardiovascular risk management. The preferred option depends on the dominant lipid abnormality, kidney and liver function, interaction risk and the evidence-based goal of treatment.

Fenofibrate is commonly dosed once daily, although the exact regimen depends on the formulation. This can be easier to fit into a routine than twice-daily gemfibrozil. When a fibrate must be considered alongside a statin, fenofibrate is often preferred because it generally has a lower interaction-related myopathy risk than gemfibrozil, but combination therapy still requires professional assessment and monitoring.

Rosuvastatin and atorvastatin are usually more appropriate when LDL cholesterol and reduction of atherosclerotic cardiovascular risk are the main priorities. A statin may also lower triglycerides to some extent, but severe hypertriglyceridaemia may call for a different or additional strategy. Gemfibrozil should not simply be added to a statin without a specific clinical review because interaction risks differ between individual statins.

If you want to understand another statin option, you can read about Zocor. You can also explore Cholesterol for broader navigation between relevant treatments. These options are not direct substitutes for Lopid unless a prescriber decides that their treatment role better matches your lipid profile.

Lopid's Status in Australia: Regulation and Access

Gemfibrozil is a Schedule 4 Prescription Only Medicine in Australia, so supplying it for therapeutic use requires a valid prescription from an authorised prescriber under Australian law. Available records do not confirm that this exact Lopid 300 mg product is currently included in the Australian Register of Therapeutic Goods under the relevant brand, strength, dosage form and sponsor, so the precise product should be checked in the ARTG when brand-specific registration matters. PBS subsidy cannot be assumed for this pack because eligibility depends on the exact PBS-listed gemfibrozil product and any applicable restriction.

Separately from that regulatory classification, our ordering policy does not require a prescription upload before we accept an order for Lopid. This describes our checkout process only and does not change gemfibrozil's legal classification in Australia or remove the need to use it under appropriate prescribing guidance. Suspected adverse reactions can be reported to the Therapeutic Goods Administration.

Ordering, Delivery and Receiving Your Lopid

We have been operating since 2018, and our pharmacist-backed support team is available 24/7 by email and online chat if you have questions before or after you order. Choose from 30, 60, 90, 120, 180, 270 or 360 capsules after checking the prescribed daily quantity and intended supply period. The listing above shows the current price and stock position for each available option.

Once payment is completed through our checkout, we pack the order for dispatch and provide an estimated delivery window. Delivery times are estimates rather than guarantees and can vary with the destination and courier conditions. Check that the delivery address and postcode are complete before submitting the order to reduce avoidable delays.

When the parcel arrives, confirm that the product name, active ingredient, 300 mg strength, capsule form and quantity match the order. Check that the packaging is intact and review the expiry and storage information before use. If the parcel contents do not match the order or the packaging appears damaged, keep the product aside and contact our support team.

Making Your Decision

Choosing Lopid 300 mg capsules comes down to whether gemfibrozil's fibrate action matches the lipid pattern that you and your prescriber are trying to manage. It is most relevant when raised triglycerides are central to the problem, not simply whenever a cholesterol result is outside the desired range. The twice-daily pre-meal regimen, major interaction risks and need for follow-up blood tests should all be practical parts of that decision.

If gemfibrozil is the confirmed choice, select a pack quantity that reflects the prescribed number of capsules and planned supply period. Our checkout does not add a prescription-upload step, and our support team is available around the clock if an ordering, payment, delivery or parcel question arises.